We are a biotechnology company developing effective and safe therapeutic treatments for Cancer with the purpose of restoring hope to patients who have no other option. We have been studying cancer and especially its relationship with inflammation for more than 7 years.
Saving lives of patients with cancer and other high-impact diseases with effective, safe, accessible and affordable treatments. With these treatments, we want to prevent suffering, pain and loss of life for millions of people around the world.
We have recently opened an investment round of which we already have part committed. We offer our investors a clear exit strategy. For more information, please contact info@plusvitech.com
Our treatments focus on the repositioning of existing drugs for reuse for other purposes. They have demonstrated effectiveness in lung cancer, breast cancer, lymphoma. We hold 20 international patents (managed by JA Kemp London). The following clinical trials are currently underway:
Our treatments are based on reestablishing balance in the cells (homeostasis). In the case of cancer, we have clinical evidence that they stop tumor progression and induce cell death (apoptosis).
Therefore, our treatments:
The Seville-based biotech closes a private investment round of 500,000 euros and receives 2.5 million euros in non-repayable funding from CDTI thanks to the European Seal of Excellence. The round,…
This prestigious international event took place on November 19 and 20 at the Four Seasons Hotel Manama, with the presence of over 500 attendees and sponsored by Prince Salman bin…
PlusVitech Wins “Most Impactful Startup” Award at LifeTech Summit 2024 We are thrilled to announce that PlusVitech has won the “Most Impactful Startup” award at the prestigious LifeTech Summit 2024,…
